Ambalal Sarabhai Enterprises Ltd

Know More
NSEBSE
Stock not tradded

55.040.40 (0.73%)

12:00 AM,2nd Mar 2024

BSE : 500009

NSE : AMBASARABH

Sector : Others

ISIN Code : INE432A01017

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Mar 02 2024 | 12:00 AM IST

Market Cap (₹ Cr)

0

Turnover (₹ Cr)

0.00

Volume (Shares)

Face Value

10

52-WK High

0.00

52-WK High Date

Invalid date

52-WK Low

0.00

52-WK Low Date

Invalid date

All Time High

28.25

All Time High Date

27 Sep 1995

All Time Low

3.05

All Time Low Date

01 Aug 2001

Ambalal Sarabhai Enterprises Ltd

Ambalal Sarabhai Enterprises Ltd produces a range of bulk drugs pharmaceutical preparations and electronic instruments. The company operates in two segments namely pharmaceuticals and electronics. Pharmaceuticals segment is engaged in manufacture of drugs and formulations. Electronics segment is engaged in manufacture of electronics instruments and services. Their subsidiaries include Synbiotics Ltd Haryana Containers Ltd Asence Inc Asence Pharma Pvt Ltd Mautik Exim Ltd Systronics ( I ) Ltd Suvik Hitek Pvt Ltd and Vovanties Lab Pvt Ltd. Ambalal Sarabhai Enterprises Ltd was incorporated on June 5 1978. The company became a public limited company in December 1980. In the year 1994 the company entered into a technical collaboration with Biobras Brazil to manufacture highly purified insulin injections. During the year 1997-98 the company formed a joint venture company namely Sarabhai Piramal Pharmaceuticals Ltd with Piramal Enterprises Ltd for marketing of certain products under trademarks being used by the company. During the year 1998-99 the company signed agreement with B V Chiron Netherlands for introducing their anti-cancer drugs in India.During the year 1999-2000 the company entered into an MoU for marketing of products of Oncology products of Chiron Corporation USA. The product division essentially comprising of Sarabai Chemicals products was transferred to the joint venture company Sarabhai Piramal Pharmaceuticals Ltd. In September 2008 the company acquired the manufacturing and marketing company namely Suvik Hitek Pvt. Ltd. The Ethical Division re-launched the products of Suvik and Sarabhai Chemicals in market. Also the company acquired Systronics (India) Pvt Ltd. During the year 2008-09 the Oncology Division launched two new products viz. Fludagem & Xtinib. Also the company promoted a company viz. Vovanties Laboratories Pvt Ltd a pharmaceutical specialist with a vision to establish a state of the art manufacturing facility specializing in Novel Effervescent drug delivery system. During the year 2010-11 the company has transferred and assigned as a going concern the undertaking and business of Sarabhai Chemicals Bulk Drug Division to Synbiotics Ltd and electronics division comprising of Systronics Teleradand SERC to Systronics (India) Ltd with effect from October 01 2010.

Ambalal Sarabhai Enterprises Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

421

EPS - TTM (₹) [S]

0.00

P/E Ratio (X) [S]

11.59

Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [S]4.75
P/B Ratio (₹) [S]11.59
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

53.35

56.39

Week Low/High

51.50

62.00

Month Low/High

51.00

70.00

Year Low/High

20.04

70.00

All time Low/High

1.57

80.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-6.36%%0.910.75%
1 Month-6.78%%2.392.40%
3 Month32.31%%9.3710.41%
6 Month68.63%%12.8815.14%
1 Year132.63%%25.2929.19%
3 Year177.28%%46.7450.00%

Company Info

Company Information

Additional Director : BRIJESH KHANDELWAL

Registered Office: Shanti Sadan, Mirzapur Road,Ahmedabad,Gujarat-380001 Ph: 91-79-25507671/25507073

Email:ketanadhvaryu@sarabhai.co.in

URL:http://www.ase.life